The study shows a reduction in the size of hepatic colorectal tumors in mice by a statistically significant margin (p = 0.005) compared to the control group, as a result of the in vivo targeting of NRP-2 by small interfering RNA (siRNA). Here, NRP2 is linked to colorectal neoplasm.